link ae888

Vietnam conditionally approves Hayat-Vax for emergency use

The Ministry of Health on September 10 issued a decision on conditionally approving the Hayat-Vax vaccine for emergency use in COVID-19 prevention and control, making it the seventh COVID-19 vaccine obtaining a licence for emergency use in Vietnam.
Vietnam conditionally approves Hayat-Vax for emergency use ảnh 1Hayat-Vax vaccine (Source: tuoitre.vn)
Hanoi (VNA) - The Ministry of Health on September 10 issued adecision on conditionally approving the Hayat-Vax vaccine for emergency usein COVID-19 prevention and control, making it the seventh COVID-19 vaccine obtaining a licencefor emergency use in Vietnam.

Accordingly, the Hayat - Vax vaccine is semi-finished by theBeijing Institute of Biological Products Co., Ltd. of China National BiotecGroup Company Limited (CNBG).

This vaccine is packaged and delivered from Julphar (GulfPharmaceutical Industries) of the United Arab Emirates (UAE).

In Vietnam, Vimedimex Pharmaceutical Joint Stock Company hadproposed for the approval of this vaccine.

Hayat-Vax is an inactivated vaccine, produced bygrowing the SARS-CoV-2 in cell culture and then using chemicals to inactivatethe virus.

The ministry asked the Drug Administration of Vietnam tolicense the import of the vaccine and abide by regulations on the management ofimport and the quality of imported vaccines.

Meanwhile, the Administration of Science Technology andTraining will select and guide qualified units to assess the vaccine's safetyand efficacy based on advice from the advisory council on use of vaccines andbiologicals.

The General Department of Preventive Medicine is responsiblefor conducting vaccination using Hayat-Vax. The ministry also assigned theNational Institute for Control of Vaccine and Biologicals to conduct checks andgrant certificates for batches of the vaccine before use.

At present, there are seven foreign COVID-19 vaccines thathave obtained a license for emergency use in Vietnam, namely AstraZeneca by AstraZeneca, Vero Cell by China National Biotec Group (CNBG)/Sinopharm, Sputnik V, Pfizer,Moderna and Johnson & Johnson, and Hayat-Vax./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🍬 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

ꦑ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

🌸 Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{dagathomo tructiep hôm nay}|{link link link ae888}|{dá gà thomo}|{trực tiếp đá gà thomo hom nay}|{sbobet asian handicap}|